Article
-174G/C IL-6 gene promoter polymorphism predicts therapeutic response to TNF-α blockers.
Pharmacogenetics and genomics - 1 Feb 2012
Di Renzo Laura, Bianchi Alessia, Saraceno Rosita, Calabrese Vittorio, Cornelius Caroline, Iacopino Leonardo, Chimenti Sergio, De Lorenzo Antonino
Abstract excerpt
BACKGROUND: Although TNF-α blockade is a very effective therapy for psoriasis, not all patients achieve a favorable outcome. The association between IL-6 and psoriasis has been investigated but no papers have focused on the pharmacogenetics of IL-6. OBJECTIVE: To examine whether the G or the C allele, at position -174 in the promoter of IL-6, influences the relationships between body weight, body composition, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
